Pay in 4 interest-free payments of $6.33 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
For those managing a diagnosed deficiency, ongoing treatments may be recommended on a consistent schedule
Having an open conversation with your surgeon about any treatments youre considering is always appropriate
FDA Status BPC-157s FDA status remains not approved for medical use or over-the-counter sale. In April 2026, compounding restrictions were adjusted, but the peptide still cannot be prescribed or sold for human/animal consumption
Rupa Health
The results are not directly comparable to systemic Thymosin Beta-4 or TB-500 administration Key distinction: TB-500 is a synthetic fragment designed to mimic aspects of Thymosin Beta-4
US$ 23.08
US$ 22.94
